Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 01-2009 | 12-2008 | 10-2008 | 07-2008 | 04-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -442,500 | -48,400 | -40,100 | 1,000 | -12,400 |
| Depreciation Amortization | 388,700 | 19,000 | 86,600 | 63,200 | 41,700 |
| Income taxes - deferred | -4,300 | -100 | 1,500 | -1,300 | -900 |
| Accounts receivable | 47,300 | 33,900 | 4,900 | 3,000 | -5,000 |
| Accounts payable and accrued liabilities | -22,900 | -4,900 | -12,700 | -24,200 | -17,100 |
| Other Working Capital | -31,100 | -28,100 | -26,100 | -43,700 | -50,500 |
| Other Operating Activity | 45,600 | 50,600 | 161,500 | 112,500 | 98,600 |
| Operating Cash Flow | $-19,200 | $22,000 | $175,600 | $110,500 | $54,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,200 | -4,800 | -42,100 | -30,500 | -19,800 |
| Net Acquisitions | 2,700 | 2,700 | -198,300 | -199,400 | -199,400 |
| Purchase Of Investment | N/A | N/A | -9,800 | -9,900 | -9,900 |
| Sale Of Investment | N/A | 11,800 | 39,700 | 39,700 | 39,700 |
| Other Investing Activity | 500 | -1,800 | -3,400 | -1,200 | 900 |
| Investing Cash Flow | $0 | $7,900 | $-213,900 | $-201,300 | $-188,500 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -900 | 451,600 | 231,100 | 432,000 |
| Debt Repayment | -1,000 | N/A | -221,100 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 500 | 400 | 300 |
| Common Stock Repurchased | -94,100 | -101,200 | -56,500 | N/A | N/A |
| Other Financing Activity | 0 | 0 | -10,700 | -10,700 | -10,700 |
| Financing Cash Flow | $-95,100 | $-102,100 | $163,800 | $220,800 | $421,600 |
| Exchange Rate Effect | -1,300 | -8,800 | -14,300 | 6,300 | 5,600 |
| Beginning Cash Position | 631,400 | 601,900 | 520,200 | 520,200 | 520,200 |
| End Cash Position | 515,800 | 520,900 | 631,400 | 656,500 | 813,300 |
| Net Cash Flow | $-115,600 | $-81,000 | $111,200 | $136,300 | $293,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,200 | 22,000 | 175,600 | 110,500 | 54,400 |
| Capital Expenditure | -7,700 | -9,200 | -42,400 | -30,700 | -19,900 |
| Free Cash Flow | -26,900 | 12,800 | 133,200 | 79,800 | 34,500 |